Home>Topics>Stocks>Progenics Pharmaceuticals

Progenics Pharmaceuticals PGNX

  1. All
  2. Commentary
  3. Headlines
    1. Ironwood Pharma begins linaclotide label expansion trial

      Headlines

      Thu, 16 Oct 2014

      adults with irritable bowel syndrome with constipation or chronic idiopathic constipation. OIC-related tickers: ( SLXP -0.6% )( PGNX +1.9% )( NKTR -0.5% )( AZN -2% )( CBST +0.1% )( SGYP +0.7% ) Post your comment!

    2. Progenics receives $40M milestone for Relistor clearance

      Headlines

      Mon, 6 Oct 2014

      FDA's approval of Relistor (methylnaltrexone bromide) for OIC triggers a $40M milestone payment to Progenics Pharmaceuticals ( PGNX -5.3% ) from worldwide collaboration partner Salix Pharmaceuticals ( SLXP -3.6% ). Under the terms

    3. Ad Comm smacks down Sonacare's HIFU device for prostate cancer

      Headlines

      Fri, 3 Oct 2014

      docs Prostate cancer therapy-related tickers:( TKAI -2.1% )( MDVN +1.2% )( NYMX +4.8% )( EXEL -0.3% )( PGNX +2.8% )( MRK +1.8% )( ADXS +2.7% )( EBS +1.8% )( EDAP +3% )( ISIS +2.1% )( NVGN )( DNDN +0.7

    4. Progenics: Inexpensive Way To Win Big 3 Potential Ways

      Headlines

      Thu, 2 Oct 2014

      By AvetCap : Since PGNX is a fairly well-known company among ..... into the sources of upside. Valuation : PGNX is trading at an enterprise value of ..... brings the valuation down to $ 213mm . PGNX also stands to receive a $50mm milestone

    5. FDA approves Salix/Progenics' Relistor

      Headlines

      Mon, 29 Sep 2014

      chronic non-cancer pain." Salix (NASDAQ: SLXP ) will sell Relistor under a license from developer Progenics (NASDAQ: PGNX ). Many expected FDA approval to arrive following a favorable July ruling . PGNX +3.4% AH. Post your comment!

    6. Ad Comm supports approval of Moventig for OIC

      Headlines

      Fri, 26 Sep 2014

      regulatory and launch milestones, tiered sales-related milestones up to $375M and double-digit royalties on net global sales. Related tickers: (NASDAQ: PGNX ) (NASDAQ: CBST ) (NASDAQ: SLXP ) (NASDAQ: SGYP ) Post your comment!

    7. Relistor in OIC PDUFA approaches

      Headlines

      Tue, 23 Sep 2014

      treatment of opioid-induced constipation (OIC). Salix ( SLXP +5% ) successfully appealed the FDA's CRL for the indication in July. ( PGNX +0.6% )( NKTR +1.8% )( AZN -4% )( CBST +0.6% )( SGYP +3.1% ) Post your comment!

    8. Azedra investigator presents long term follow-up data

      Headlines

      Mon, 22 Sep 2014

      International Symposium of Pheochromocytoma and Paraganglioma in Kyoto, Japan on data from a Phase 2 trial of Progenics Pharmaceuticals ' ( PGNX -3.1% ) Azedra (Ultratrace Iobenguane I-131). Azedra is the company's radio-therapeutic candidate

    9. FDA clears OIC drug

      Headlines

      Tue, 16 Sep 2014

      induced constipation who take opioids for the management of chronic non-cancer pain. Movantik is distributed by AstraZeneca ( AZN -0.9% ). Related tickers: ( PGNX -0.2% ) ( SLXP +3.7% ) ( CBST +0.1% ) Post your comment!

    10. Progenics Pharma settles arbitration with Ono Pharma

      Headlines

      Fri, 5 Sep 2014

      Progenics Pharmaceuticals ( PGNX -2.4% ) settles its arbitration with Ono Pharmaceutical Company over Ono's rights to subcutaneous Relistor in Japan and its

    « Prev12345Next »
    Content Partners